Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes

Drug Metabolism and Disposition

Volumn 25, Issue 3, 1997, Pages 390-393

  Guo, Zuyu ^b   Raeissi, Shamsi ^a   White, Rebecca B ^b   Stevens, Jeffrey C ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b NW12 ^*

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; CYTOCHROME P450; ORPHENADRINE; THIAMAZOLE; UNSPECIFIC MONOOXYGENASE;

ARTICLE; DRUG ACTIVITY; DRUG INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MICROSOME; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; ANTITHYROID AGENTS; BINDING, COMPETITIVE; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INHIBITORS; HUMANS; ISOENZYMES; METHIMAZOLE; MICROSOMES, LIVER; ORPHENADRINE; SENSITIVITY AND SPECIFICITY;

EID: 0030891968     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. F. P. Guengerich and T. Shimada: Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4, 391-407 (1991).
2. D. J. Birkett, P. I. Mackenzie, M. E. Veronese, and J. O. Miners: In vitro approaches can predict human drug metabolism. Trends Pharmacol. Sci. 14, 292-294 (1993).
3. D. J. Newton, R. W. Wang, and A. Y. H. Lu: Cytochrome P450 inhibitors - evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab. Dispos. 23, 154-158 (1995).
4. G. F. Reidy, I. Mehta, and M. Murray: Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics. Mol. Pharmacol. 35, 736-743 (1989).
5. T. K. H. Chang, G. F. Weber, C. L. Crespi, and D. J. Waxman: Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes. Cancer Res. 53, 5629-5637 (1993).
6. A. Dixit and T. E. Roche: Spectrophotometric assay of the flavin-containing monooxygenase and the changes in its activity in female mouse liver with nutritional and diurnal conditions. Arch. Biochem. Biophys. 233, 50-63 (1984).
7. G. L. Kedders and D. E. Rickert: Loss of rat microsomal cytochrome P-450 during methimazole metabolism: role of flavin-containing monooxygenase. Drug Metab. Dispos. 13, 58-61 (1985).
8. P. W. Lee and R. A. Neal: Metabolism of methimazole by rat liver cytochrome P-450-containing monooxygenases. Drug Metab. Dispos. 6, 591-600 (1978).
9. G. L. Kedders and D. E. Ricket: Inhibition of the microsomal N-hydroxylation of 2-amino-6-nitrotoluene by a metabolite of methimazole. Biochem. Biophys. Res. Commun. 113, 433-438 (1983).
10. R. E. Tynes and E. Hodgson: Oxidation of thiobenzamide by the FAD-containing and cytochrome P-450-dependent monooxygenases of the liver and lung microsomes. Biochem. Pharmacol. 32, 3419-3428 (1983).
11. C. B. Frederick, J. B. Mays, D. M. Ziegler, F. P. Guengerich, and F. F. Kadlubar: Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA. Cancer Res. 42, 2671-2677 (1982).
12. P. P. Wang, P. Beaue, L. S. Kaminsky, G. A. Dannan, F. F. Kadlubar, D. Larrey, and F. P. Guengerich: Purification and characterization of six cytochrome P-450 isozymes from human liver microsomes. Biochemistry 22, 5375-5383 (1983).
13. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275 (1951).
14. T. Omura and R. Sato: The carbon monooxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378 (1964).
15. M. Sattler, F. P. Guengerich, C.-H. Yun, U. Christians, and K.-F. Sewing: Cytochrome P450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab. Dispos. 20, 753-761 (1992).
16. R. Pearce, D. Greenway, and A. Parkinson: Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch. Biochem. Biophys. 298, 211-225 (1992).
17. J. T. M. Buters, C. D. Schiller, and R. C. Chou: A high sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man: direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoroethylcoumarin. Biochem. Pharmacol. 46, 1577-1584 (1993).
18. R. Knodell, S. Hall, G. Wilkinson, and F. P. Guengerich: Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. J. Pharmacol. Exp. Ther. 241, 1112-1119 (1987).
19. U. Meier, T. Kronbach, and U. Meyer: Assay of mephenytoin metabolism in human liver microsomes by high-performance liquid chromatography. Anal. Biochem. 151, 286-291 (1985).
20. T. Kronbach, D. Mathys, J. Gut, T. Catin, and U. Meyer: High performance liquid chromatographic assays for bufuralol 1′-hydroxylase, debrisoquine 4-hydroxylase, and dextromethorphan O-demethylase in microsomes and purified cytochrome P450 isozymes of human liver. Anal. Biochem. 162, 24-32 (1987).
21. R. Peter, R. Bocker, P. Beaune, M. Iwasaki, F. Guengerich, and C.-S. Yang: Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem. Res. Toxicol. 3, 566-573 (1990).
22. F. P. Guengerich, M. V. Martin, P. Beaune, P. Kremers, T. Wolff, D. Waxman: Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. J. Biol. Chem. 261, 5051-5060 (1988).
23. F. P. Guengerich: Human cytochrome P450 enzymes. In "Cytochrome P450: Structure, Mechanism, and Biochemistry" (P. R. Ortiz de Montellano, ed.), 2nd ed.), pp. 473-535. Plenum Press, New York, 1995.
24. R. A. Robson, J. O. Miners, A. P. Matthews, I. Stupans, D. Meller, M. E. McManus, and D. J. Birkett: Characterisation of theophylline metabolism by human liver microsomes: inhibition and immunochemical studies. Biochem. Pharmacol. 37, 1651-1659 (1985).